• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Homeostasis of vascular vessels and prevention of atherosclerosis by vasohibin-1

Research Project

Project/Area Number 22590821
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionTohoku University

Principal Investigator

MIYASHITA Hiroki  東北大学, 加齢医学研究所, 助教 (80302222)

Co-Investigator(Kenkyū-buntansha) SATO Yasufumi  東北大学, 加齢医学研究所, 教授 (50178779)
Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords(1)バソヒビン / (2)血管新生抑制因子 / (3)細胞の老化 / (4)動脈硬化 / バソヒビン / 血管新生抑制因子 / 細胞の老化 / 動脈硬化
Research Abstract

Vasohibin-1 (VASH1) is isolated as an endothelial cell (EC)-produced angiogenesis inhibitor. We questioned whether VASH1 plays any role besides angiogenesis inhibition, knocked-down or overexpressed VASH1 in ECs, and examined the changes of EC property. Knock-down of VASH1 induced premature senescence of ECs, and those ECs were easily killed by cellular stresses. In contrast, overexpression of VASH1 made ECs resistant to premature senescence and cell death caused by cellular stresses. The synthesis of VASH1 was regulated by HuR-mediated post-transcriptional regulation. We sought to define the underlying mechanism. VASH1 increased the expression of (superoxide dismutase2) SOD2, an enzyme known to quench reactive oxygen species (ROS). Simultaneously, VASH1 augmented the synthesis of sirtuin 1 (SIRT1), an anti-aging protein, which improved stress tolerance.Paraquat generates ROS and causes organ damage when administered in vivo. More VASH1 (+/-) mice died due to acute lung injury caused by paraquat. Intratracheal administration of an adenovirus vector encoding human VASH1 augmented SOD2 and SIRT1 expression in the lungs and prevented acute lung injury caused by paraquat. Thus, VASH1 is a critical factor that improves the stress tolerance of ECs viathe induction of SOD2 and SIRT1.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (4 results)

All 2012 2011 2010

All Journal Article (3 results) (of which Peer Reviewed: 1 results) Presentation (1 results)

  • [Journal Article] angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT12012

    • Author(s)
      Miyashita H, Watanabe T, Hayashi H, Suzuki Y, Nakamura T, Ito S, Ono M,Hoshikawa Y, Okada Y, Kondo T, Sato Y.
    • Journal Title

      PLoS One

      Volume: 7

    • Related Report
      2012 Final Research Report
  • [Journal Article] Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT12012

    • Author(s)
      宮下浩輝
    • Journal Title

      PloSOne

      Volume: 7 Issue: 10 Pages: e46459-e46459

    • DOI

      10.1371/journal.pone.0046459

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mutual Balance betweenVasohibin-1 and Soluble VEGFR-1 inEndothelial Cells2011

    • Author(s)
      Miyashita H, Suzuki H, Ohkuchi A, Sato Y.
    • Journal Title

      Pharmaceuticals

      Volume: 4 Pages: 1551-1577

    • Related Report
      2012 Final Research Report
  • [Presentation] 内皮ストレス耐性におけるsplicing variant vasohibin-1の意義2010

    • Author(s)
      宮下浩輝、佐藤靖史
    • Organizer
      第18回日本血管生物医学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2010-12-01
    • Related Report
      2012 Final Research Report 2010 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi